Last updated on September 2018

Extending the Time for Thrombolysis in Emergency Neurological Deficits

Brief description of study

The primary hypothesis being tested in this trial is that ischaemic stroke patients selected with significant penumbral mismatch (measured by MRI criteria) at 3 - 9 hours post onset of stroke will have improved clinical outcomes when given intravenous tissue plasminogen activator (tPA) compared to placebo.

Clinical Study Identifier: NCT00887328

Contact Investigators or Research Sites near you

Start Over

Turgut Tatlisumak

Helsinki University Central Hospital
Helsinki, Finland